In recent years, CF treatment has focused on the use of correctors and potentiators, such as lumacaftor, ivacaftor, tezacaftor and elexacaftor (collectively known as modulators), to improve CFTR function [49,50,51,52,53]. Here, CFTR is linked to cystic fibrosis.